Figure 2From: Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trialEstimated Cumulative Incidence Functions for the Time-to-Progression for the two treatment groups.Back to article page